GENE SILENCING THROUGH RNA INTERFERENCE IN ORAL SQUAMOUS CELL CARCINOMA

Oral squamous cell carcinoma (OSCC) is the predominant histological subtype of oral cancer and remains a significant global health challenge. Conventional treatments, including surgery, radiotherapy, and chemotherapy, can cause substantial morbidity, while tumour recurrence, metastasis, and therapeutic resistance continue to affect clinical outcomes. RNA interference (RNAi) is an emerging molecular approach that enables sequence-specific regulation of gene expression and offers opportunities for targeted cancer therapy. This review examines the molecular mechanisms of RNA interference and evaluates its potential applications in OSCC, with particular emphasis on small interfering RNA (siRNA), microRNA (miRNA), oncogenic signaling pathways, targeted delivery systems, and translational limitations. RNAi-mediated gene regulation offers a potential strategy for suppressing oncogenic pathways associated with tumour proliferation, apoptosis resistance, invasion, metastasis, and treatment resistance. siRNA can selectively degrade complementary messenger RNA, whereas miRNA mimics and inhibitors can modify broader post-transcriptional regulatory networks. Lipid nanoparticles, polymeric nanocarriers, liposomes, and extracellular vesicles are being investigated to improve RNA stability and intracellular delivery. Nevertheless, inefficient tumour targeting, endosomal entrapment, off-target effects, immune activation, and limited OSCC-specific clinical validation remain major challenges. RNA interference represents a promising research direction for precision oncology in OSCC. Future progress will depend on validated molecular targets, effective delivery systems, comprehensive safety assessment, and rigorous clinical evaluation. At present, RNAi-based approaches should be regarded as investigational strategies rather than established treatments for OSCC.

Authors

Publication Details

Journal
International Journal of Innovative Research in Technology
Published
2026-11-19
DOI
https://doi.org/10.64643/ijirt211253
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

GENE SILENCING THROUGH RNA INTERFERENCE IN ORAL SQUAMOUS CELL CARCINOMA

Periasamy Asokan Jayasri, Dhivya Velusamy, Bhavadharani Manickavasagam, Dhinesh Kumar et al.
International Journal of Innovative Research in Technology
RNA Interference and Gene Delivery
article

GENE SILENCING THROUGH RNA INTERFERENCE IN ORAL SQUAMOUS CELL CARCINOMA

Periasamy Asokan Jayasri, Dhivya Velusamy, Bhavadharani Manickavasagam, Dhinesh Kumar, Ezhilarasan Murugesan, Danishtha Mohanraj, Bhuvana Devi Navaneetha Gopal, Bharath Praveen Kumar Sivasundar
article en

Abstract

Oral squamous cell carcinoma (OSCC) is the predominant histological subtype of oral cancer and remains a significant global health challenge. Conventional treatments, including surgery, radiotherapy, and chemotherapy, can cause substantial morbidity, while tumour recurrence, metastasis, and therapeutic resistance continue to affect clinical outcomes. RNA interference (RNAi) is an emerging molecular approach that enables sequence-specific regulation of gene expression and offers opportunities for targeted cancer therapy. This review examines the molecular mechanisms of RNA interference and evaluates its potential applications in OSCC, with particular emphasis on small interfering RNA (siRNA), microRNA (miRNA), oncogenic signaling pathways, targeted delivery systems, and translational limitations. RNAi-mediated gene regulation offers a potential strategy for suppressing oncogenic pathways associated with tumour proliferation, apoptosis resistance, invasion, metastasis, and treatment resistance. siRNA can selectively degrade complementary messenger RNA, whereas miRNA mimics and inhibitors can modify broader post-transcriptional regulatory networks. Lipid nanoparticles, polymeric nanocarriers, liposomes, and extracellular vesicles are being investigated to improve RNA stability and intracellular delivery. Nevertheless, inefficient tumour targeting, endosomal entrapment, off-target effects, immune activation, and limited OSCC-specific clinical validation remain major challenges. RNA interference represents a promising research direction for precision oncology in OSCC. Future progress will depend on validated molecular targets, effective delivery systems, comprehensive safety assessment, and rigorous clinical evaluation. At present, RNAi-based approaches should be regarded as investigational strategies rather than established treatments for OSCC.

International Journal of Innovative Research in TechnologyVol. 13(6)
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon